Clinical Trial Transparency Hits the C-Suite

Posted by Thomas Wicks on Jul 29, 2015 4:25:40 PM


You may have seen clinical trial transparency in the news last week as international publications like the Wall Street Journal and Financial Times covered the topic. A collection of 85 different asset managers and pension funds from the US, EU and Australia aligned with the AllTrials initiative to urge clinical trial sponsors to be more transparent with clinical trial data.

Read More

0 Comments | Click here to read/write comments

Topics: Clinical Trial Disclosure

Introduction to Clinical Trial Disclosure

Posted by Francine Lane on Jun 5, 2015 12:13:50 PM


Are you new to disclosure and don’t know where to start?  This is the first in a series of “Back to Basics” on clinical trial disclosure and is intended to help navigate the challenging world of disclosure.

Disclosure in clinical trials is becoming relevant to more and varied organizations.  Once the domain of large pharmaceutical and biotech companies, smaller biopharma, academic, and research organizations are paying close attention to disclosure.  Read on to find out why.

Read More

0 Comments | Click here to read/write comments

Topics: Clinical Trial Disclosure

Alignment: A Big Hurdle in Clinical Trial Disclosure

Posted by Monique Garrett on Nov 19, 2014 12:16:00 PM


Clinical trial disclosure can be a very complex and time consuming process. Sponsors spend a great deal of time and effort ensuring that disclosed data is accurate and timely. But when a sponsor has to disclose data in different formats, at different times, to different registries (or to their own branded websites), the task becomes increasingly complex. The management of living content that is constantly moving and changing can be a significant challenge. And that is why alignment - of content and of supporting organizational structures - is critical. 

Read More

0 Comments | Click here to read/write comments